News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Drug Product News
Lupin (LUPN.BO) Bolsters US Brands Portfolio With Methergine Oral Tablets 4/29/2016
Heritage Pharmaceuticals Issues Product Safety Warning Due To Reported Sales Of Counterfeit Drug Product Labeled As BiCNU (Carmustine For Injection) 100mg Outside Of The United States 4/29/2016
Mineral Biosciences GlyDe D Undercuts Today's Sugar Metabolism Problem 4/29/2016
Zambon Launches Xadago (Safinamide) In Denmark And Sweden For Patients With Mid- To Late-Stage Parkinson’s Disease 4/28/2016
This Gin Is Supposed To Make Its Drinkers Look Younger 4/27/2016
Merial Launches Combination Vaccine To Help Prevent Core Canine Diseases And Provide Comprehensive Leptospirosis Protection 4/27/2016
Derma Sciences (DSCI) Announces AMNIOEXCEL Is Now Eligible For Reimbursement By Medicare Administrative Contractor CGS 4/27/2016
Galderma Laboratories Unveils The New Cetaphil Brand Graphics & Packaging 4/26/2016
ANDROXY (Fluoxymesterone Tablets, USP) CIII Available Exclusively Through Upsher-Smith Laboratories 4/25/2016
Fighting Cancer With Killer T-Cells: 5 Developments To Watch 4/22/2016
BOC Sciences Enriched Description Content For 13 Featured Products 4/21/2016
Half Of Evonik Industries's Sales Are Generated With Products For Resource-Efficient Applications 4/21/2016
Spotlight Innovation Achieves Key Laboratory Benchmark For Its Immunoplex Immunotherapy Cancer Vaccine Technology 4/21/2016
Fresenius Kabi AG Introduces Linezolid Injection 600 Mg Per 300 Ml In Freeflex Bags 4/21/2016
Merck Canada Inc. Release: New Treatment Now Available For Canadians With Metastatic Non-Small Cell Lung Cancer 4/20/2016
Venclextatm (Venetoclax) Approved For Chronic Lymphocytic Leukemia, Available At Biologics, Inc. (NC) 4/20/2016
Eagle Pharma (EGRX) Release: CMS Determines that Existing J-Code J9033 Adequately Describes BENDEKA (bendamustine hydrochloride) Injection 4/20/2016
Medicinal Genomics Revolutionizes Cannabis Industry With Introduction Of Strain ID & Certification Service 4/20/2016
Tris Pharma, Inc. Announces The Launch Of DYANAVEL XR (Amphetamine) Extended-Release Oral Suspension, CII For The Treatment Of Children With ADHD 4/19/2016
Diplomat Specialty Pharmacy To Dispense VENCLEXTA For The Treatment Of Chronic Lymphocytic Leukemia 4/19/2016
Invitae Announces Medicare Reimbursement For Hereditary Breast Cancer-Related Disorders Under A New CPT Code For Multi-Gene Panels 4/19/2016
Baxter International (BAX) Announces U.S. Launch Of Premix Drug VANCOMYCIN Injection In Sodium Chloride 4/19/2016
Promius Pharma, LLC Release: ZEMBRACE Symtouch (Sumatriptan Injection) 3 Mg, Approved By The FDA In January 2016 For The Acute Treatment Of Migraine With Or Without Aura In Adults, Is Now Commercially Available In The U.S. 4/19/2016
PTC Therapeutics (PTCT) Release: National Institute for Clinical Excellence (NICE) Recommends Translarna (Ataluren) For The Treatment Of Patients With Nonsense Mutation Duchenne Muscular Dystrophy In England 4/15/2016
Genovis Launches GingisREX And Expands Product Portfolio 4/14/2016
Two Reasons To Take Aspirin Regularly, One Reason Not To. What Should You Do? 4/13/2016
IMPAX Labs (IPXL) Announces Availability of EMVERM (mebendazole) Chewable Tablets, 100 mg 4/13/2016
Why Chinese Parents Are Shopping For Vaccines In Hong Kong 4/13/2016
Palmetto Medicare Now Covering Amniox Medical Products 4/13/2016
Martindale Pharma Launches First Ready-To-Use Presentation Of Phenylephrine 4/12/2016
GE Healthcare Expands European Capabilities To Support Accelerated Biomanufacturing 4/12/2016
KaloBios (KBIO)' New CEO Distances Himself Even Further from Shkreli With Drug Pricing Promise 4/11/2016
Mylan (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Generic Lopressor Tablets 37.5 Mg And 75 Mg 4/11/2016
Midatech’s Commercial Launch Of Zuplenz (Ondansetron) Oral Soluble Film To Prevent Post-Operative, Chemotherapy And Radiation-Induced Nausea And Vomiting In U.S. 4/11/2016
FDA Takes Steps To Withdraw Approval Of The Swine Drug Carbadox Due To Safety Concerns 4/11/2016
Silk Therapeutics Introduces New Collection Of Anti-Aging Skincare Products 4/11/2016
Osiris (OSIR) Announces Further Expansion Of Grafix Commercial Coverage 4/8/2016
Amgen (AMGN) Flinches Over Meeting to Review Cost of Multiple Myeloma Drugs 4/7/2016
TapImmune (TPIV) Completes GMP Manufacturing And Release Of TPIV 200 Vaccine 4/7/2016
Antegrin Therapeutics Expands Portfolio With Orally Available Integrin Antagonists 4/6/2016
Cipher Pharma (DND.TO) Announces Canadian Launch Of Beteflam 4/6/2016
Lupin (LUPN.BO) Launches Generic Intermezzo Sublingual Tablets In The US 4/6/2016
Mylan (MYL) Launches Generic Epivir Tablets 4/6/2016
Family-Run Drugmaker Jacobus Pharma Fights to Stay Alive in the Martin Shkreli Era of High Priced Drugs 4/5/2016
ANI Pharma Announces Launch Of Hydrocortisone Rectal Cream 1% And 2.5% 4/5/2016
3 Stories Of Pharma Outsourcing: Wellstat Therapeutics, Ramsey Lake, And Flexion (FLXN) 4/5/2016
Some People Really Can't Take Statins For High Cholesterol, Cleveland Clinic Scientists Reveal 4/5/2016
Massachusetts Biotech Companies Debate Innovative Pricing Structures for Transformative Medicines 4/4/2016
MEDISTIK Professional Line Launched For Clinics 4/4/2016
BTG plc (BTG.L) Announces US Launch Of LC Bead LUMI, Ground-Breaking Radiopaque Embolic Bead 4/1/2016
Merz Aesthetics (Formerly Known as BioForm Medical, Inc.) Release: Cellfina System Launches Nationwide At The American Society For Aesthetic Plastic Surgery 4/1/2016
Biofrontera AG Release: Swiss Compulsory Health Insurance Reimburses Ameluz For Treatment Of Actinic Keratosis 4/1/2016
Sandoz Canada Launches Prtobramycin INHALATION SOLUTION, A Generic Version Of Prtobi Indicated For Pulmonary Infections In Cystic Fibrosis Patients 3/31/2016
Tainted Heparin May Still Be in U.S. Almost Decade After Deaths 3/31/2016
Flamel Technologies (FLML) Files Special Protocol Assessment For Once Nightly Sodium Oxybate 3/31/2016
FDA's Big Task: Stop The Next Martin Shkreli and Valeant (VRX) 3/30/2016
Why Valeant (VRX) Execs Could Learn A Lot from Allergan (AGN) 3/29/2016
Mylan (MYL) Launches Generic Ultram Extended-Release Tablets 3/29/2016
SELLAS Receives USAN Approval For Generic Name Of Galinpepimut-S For WT1 Vaccine, SELLAS's Late Clinical-Stage Cancer Immunotherapy Candidate 3/29/2016
7 Potential Blockbuster Drugs May Hit the Market This Year 3/28/2016
FDA Scorns Eagle Pharma (EGRX)'s Seven Year Orphan Drug Exclusivity Request for Blood Cancer Drug BENDEKA 3/28/2016
Free Cancer Tumor Gene Screening Raises Eyebrows, Contextual Genomics Reveals 3/28/2016
Birth Of The $1 Diarrhea Vaccine 3/28/2016
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines 3/25/2016
Johnson & Johnson (JNJ) and Roche (RHHBY) Could Be the Storm Off Celgene (CELG)’s Horizon 3/25/2016
Valeant (VRX) Doubled the Price of a Drug that Helped Terminally Ill People Die 3/25/2016
China's Vaccine Scandal Reveals System's Flaws 3/25/2016
Cumberland Pharmaceuticals (CPIX) Release: Caldolor Launched For The Treatment Of Pain And Fever In Children 3/24/2016
Ajanta Pharma Announces The Launch Of Levetiracetam Tablets 3/24/2016
Amneal Announces The Launch Of Diclofenac Sodium Topical Gel 1% 3/24/2016
Merrimack (MACK) Announces Inclusion of ONIVYDE (Irinotecan Liposome Injection) As A Category 1 Treatment Option In The 2016 NCCN Guidelines For Pancreatic Adenocarcinoma 3/24/2016
Perrigo (PRGO) And Allergan (AGN) Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex 1200mg ER Tablets 3/23/2016
Aceto Subsidiary, Rising Pharma, To Launch Lithium Carbonate Extended-Release Tablets And Metronidazole Tablets 3/23/2016
Profounda, Inc. Launches Impavido (miltefosine), The First And Only Oral Rx Treatment For Visceral, Mucosal And Cutaneous Leishmaniasis, In The United States 3/22/2016
VisiVite Announces ProVision AREDS 2 Formula: Low-Cost Solution for Macular Degeneration Support 3/22/2016
Aprecia Release: First FDA-Approved Medicine Manufactured Using 3d Printing Technology Now Available 3/22/2016
Apotex Launches First Generic Version Of Merck & Co. (MRK)'s Nasonex 3/22/2016
First Ever To Market: Epicor Fast-Acting Throat Lozenge, Viralex Soothe 3/22/2016
$90 Million China Vaccine Scandal Prompts Angry Backlash From Parents And Doctors 3/22/2016
Teva (TEVA) Announces Launch Of Generic Campral® In The United States 3/22/2016
Teligent Announces Launch Of Cefotan (Cefotetan For Injection) 3/21/2016
CSL Behring Release: IDELVION For Hemophilia B Now Available In The U.S. 3/21/2016
Endo International (ENDP) Provides Statement Regarding Expected FDA Approval Of Generic Voltaren Gel Product 3/21/2016
B. Braun Medical To Launch The Only Macro And Micro Compounder With 26-Lead Preassembled Sets 3/21/2016
Martindale Pharma Re-Launches Methadone Range In Scandinavia 3/21/2016
How Generic Gleevec Will Hurt Novartis AG (NVS)—But Save Millions In Health Costs 3/18/2016
BOC Sciences Listed Lithium Aluminium Deuteride As A Featured Product 3/18/2016
Innovus Pharma Announces The Availability Of Androferti In The U.S. 3/18/2016
FDA Makes One Small Regulatory Change in Effort to Stop the Next Martin Shkreli 3/17/2016
Allergan (AGN) Announces U.S. Availability of VRAYLAR (cariprazine) For Treatment Of Bipolar Mania And Schizophrenia In Adults 3/16/2016
Evonik Launches New Formulation Technology For The Development Of Alcohol Resistant Drug Products 3/11/2016
Proud Latvia Regrets Ban On Meldonium Drug Its Scientists Invented 3/10/2016
BTG International Canada Expands Operations To Directly Sell Interventional Oncology Products 3/10/2016
Breast Cancer Pipeline Has More than 1,000 Drugs in Development 3/9/2016
Biologics, Inc. (NC) To Be Exclusive Specialty Pharmacy Provider For Vistogard (Uridine Triacetate) 3/9/2016
Teva (TEVA) Completes Generic Pulmicort Respules Portfolio With The Launch Of Third Strength In The United States 3/9/2016
Boehringer Ingelheim Release: Praxbind (idarucizumab), Specific Reversal Agent for Pradaxa (dabigatran etexilate mesylate), Now Stocked In More Than 2,200 Hospitals 3/8/2016
How a $150,000 Drug Created with Bristol-Myers Squibb (BMY) Saved Ono Pharma 3/7/2016
UCLA Sells Royalty Rights Connected with Cancer Drug to Royalty Pharma for $1.14 Billion 3/7/2016
Antera Therapeutics Announces First And Only Commercial Product Based On LEAP For Early Peanut Introduction 3/7/2016
Experimental Drug Shows Early Promise In Treating Male Baldness, Samumed Reveals 3/7/2016
Zika Virus Guidance From FDA Notes Safety Of Plasma Protein Products And The Availability Of Octapharma AG’s Octaplas 3/7/2016
Mineral Biosciences Offers Blood Sugar Control Product Nationally 3/4/2016
Altan Pharma Announces The Launch Of Linezolid 2mg/Ml Solution For Infusion In Spain 3/3/2016
Gensco Laboratories Launches The First Transdermal Medication For Acute Gout Flares With Copay And Cash Pay Assistance For Patients 3/3/2016
Allergan (AGN) Launches Bold Access To LILETTA (levonorgestrel-releasing intrauterine system) 3/3/2016
AstraZeneca PLC (AZN) Patient Assistance Programs Provided Hundreds Of Millions Of Dollars Of Support In 2015 To Help Patients Afford Medicines 3/3/2016
NovoCure Release: Humana, Inc. (HUM) Issues Positive Coverage Decision For Optune 3/3/2016
Derma Sciences (DSCI)’ AMNIOEXCEL Now Eligible For Reimbursement By Medicare Administrative Contractor WPS 3/3/2016
Kite Pharma (KITE)'s CEO On Cancer-Killing T-Cells: "This Is A Revolution" 2/29/2016
Health Canada Issues Notice Of Compliance For Gilead (GILD)'s Truvada For Reducing The Risk Of Sexually Acquired HIV Infection 2/29/2016
PTC Therapeutics (PTCT) Provides Update On German Pricing And Reimbursement Process For Translarna (ataluren) 2/29/2016
Zambon Launches Xadago (Safinamide) In Italy For Patients With Mid- To Late-Stage Parkinson’s Disease 2/29/2016
Pharma's Big New Cancer Drug May Be An Old Red Dye 2/26/2016
Adapt Pharma Release: NARCAN (Naloxone Hydrochloride) NASAL SPRAY Now Available In The United States For Emergency Treatment Of Known Or Suspected Opioid Overdose 2/26/2016
Nine Cancer Centers Accuse Genentech (RHHBY) of Shipping Less Herceptin than Promised 2/25/2016
Massachusetts AG Demands to See Documents Related to Gilead (GILD)'s Hep C Treatments 2/25/2016
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine Recognized As A New Option With Demonstrated Superior Efficacy* For Adults 65 Years And Older 2/24/2016
Sanofi US (SNY) To Return Auvi-Q (epinephrine injection, USP) Rights To Kaleo 2/24/2016
GlaxoSmithKline (GSK) President’s "Eight Terrifying Words" Face Systemic Challenges in U.S. 2/24/2016
CSL Behring Release: First Export Of Privigen From New Manufacturing Facility In Broadmeadows, Melbourne, Australia 2/23/2016
AEterna Zentaris (AEZS) Commences Promotional Activities For APIFINY Prostate Cancer Blood Test 2/23/2016
PharmaRoth Labs Provides Update On Registration Process To Market And Distribute Sucanon In India 2/23/2016
Medicare Contractor Will Not Cover St. Jude Medical (STJ)’s Cardiomems Heart Monitor 2/22/2016
Cipher Pharma (DND.TO) Announces Canadian Launch Of Actikerall 2/22/2016
Endo International (ENDP) Announces Launch of BELBUCA (Buprenorphine) Buccal Film for Chronic Pain Management 2/22/2016
BioDelivery (BDSI) Announces The Launch Of BELBUCA (buprenorphine) Buccal Film By Endo Pharma (ENDP) For Chronic Pain Management 2/22/2016
Merck Canada Inc. Release: New Antibiotic Against Drug-Resistant Bacteria Now Available 2/22/2016
Lipogen Ltd. Targets PMS/PMDD Relief, Naturally 2/22/2016
Zambon Launches Xadago (Safinamide) In Spain For Patients With Mid- To Late-Stage Parkinson’s Disease 2/22/2016
Cipher Pharma (DND.TO) Launches A Foam Preparation Of Bionect 2/17/2016
Boehringer Ingelheim Release: Praxbind (idarucizumab) Reimbursed In England, Ireland And Wales 2/17/2016
Iroko Pharmaceuticals Release: VIVLODEX Now Available In U.S. Pharmacies For The Management Of Osteoarthritis Pain 2/16/2016
National Institute for Clinical Excellence (NICE) Okays Medtronic (MDT) Veo System for Certain Type 1 Diabetics 2/12/2016
Ex-FDAAdvisoryCommittee.com Head Accused of Conspiring to Suppress Information About Harmful Effects of Johnson & Johnson (JNJ) Antibiotic 2/11/2016
InDex Pharmaceuticals AB Receives Approval Of The International Nonproprietary Name (INN) Cobitolimod For Their Lead Drug Candidate Kappaproct 2/10/2016
Trxade Group Launches HCTZ (Hydrochlorothiazide) to Treat Fluid Edema 2/9/2016
Three Drugs Could Catapult Three Big Pharma Revenues This Year 2/9/2016
Merz Neurosciences Announces Nationwide Availability Of New 200-Unit Vial Of Xeomin (Incobotulinumtoxina) 2/9/2016
Sandoz Canada Expands Its Cancer Medication Portfolio With The Launch Of (PR) Oxaliplatin Injection 2/5/2016
Boehringer Ingelheim Release: SPIRIVA RESPIMAT Now Available In The U.S. For Maintenance Treatment Of Asthma In Adults And Adolescents 2/4/2016
Emails Reveal Turing, Valeant (VRX) Price Increases Were Basis for Revenue Growth 2/3/2016
Specialised Therapeutics Asia To Distribute Novel Multiple Myeloma Drug APLIDIN In South East Asia, Australia And New Zealand 2/3/2016
Boehringer Ingelheim Release: SPIRIVA RESPIMAT Now Available In The U.S. For Maintenance Treatment Of Asthma In Adults And Adolescents 2/3/2016
Admedus Release: Cardiocel First Sales In MENA Region 2/3/2016
Vensun Pharmaceuticals Announces Launch Of Carisoprodol Tablets, USP, 250 Mg 2/3/2016
Sun Pharma (SUNPHARMA.NS) Hopes Cut-Price Generic Gleevec Will Win Third Of U.S. Market 2/2/2016
Lupin (LUPN.BO) Launches Generic Glumetza HCI ER Tablets In The US 2/2/2016
Eagle Pharma (EGRX) Announces Commercial Availability Of Docetaxel Injection, Non-Alcohol Formula 2/2/2016
AVA Biochem, World Leader In 5-HMF, Adds FDCA To Its Product Portfolio 2/1/2016
ExeGi Pharma Launches Visbiome Probiotic 2/1/2016
Sun Pharma (SUNPHARMA.NS) Launches Imatinib Mesylate In USA 2/1/2016
AlchePharma Launches Tripeptide-2X with AmealPeptide, For Cardiovascular Health 1/29/2016
Valeant (VRX) Has Found Another Enemy in Democratic Presidential Candidate Hillary Clinton 1/29/2016
Massive Problem Martin Shkreli Zeroed-In On Is Happening Again 1/28/2016
Gilead (GILD) Faces Lawsuits over AIDS Drug Patents, Threats of Lawsuits for Hepatitis C Treatments 1/28/2016
Sinovac Biotech Ltd. (SVA) Announces Issuance Of GMP Certificate For EV71 Vaccine 1/28/2016
Teva (TEVA) And Eagle Pharma (EGRX) Announce Commercial Availability Of BENDEKA (Bendamustine Hydrochloride) Injection 1/28/2016
Lightlake (LLTP) Announces Adapt Pharma To Offer All U.S. High Schools A Free Narcan (Naloxone Hydrochloride) Nasal Spray And Fund School-Based Opioid Overdose Education 1/27/2016
Novo Nordisk A/S (NVO) Launches Tresiba (insulin Degludec Injection 200 Units/Ml) In The United States 1/26/2016
VitaMedMD Launches VitaTrue, The First Certified Vegan And Kosher Prescription Prenatal Multivitamin 1/26/2016
Theravance Biopharma (TBPH) Announces Commercial Launch Of VIBATIV (telavancin) In Canada 1/26/2016
Milestone Pharmaceuticals Announces USAN Approval Of Generic Name "Etripamil" For Its Phase 2 Clinical Development Product For The Treatment Of Paroxysmal Supraventricular Tachycardia 1/25/2016
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Zolmitriptan Tablets 1/25/2016
Piramal Critical Care And Cumberland Pharmaceuticals (CPIX) Announce Launch Of Caldolor And Vaprisol Co-Promotion 1/25/2016
Plandai Biotechnology, Inc. (PLPL.OB) Announces Phytofare Sales On Three Continents 1/25/2016
Congress Subpoenas Martin Shkreli to Testify About Drug Pricing, Shkreli May Plea the Fifth 1/22/2016
Cardiome Pharma Corp. (COM.TO) Announces The Launch Of ESMOCARD LYO In Belgium 1/21/2016
Off Label Use of Roche (RHHBY)’s Avastin in India Puts 15 in the Hospital, Prompts Officials to Halt Using the Drug 1/21/2016
NextSource Biotechnology Gains FDA Approval For New 5 Mg Strength Of Gleostine® (Lomustine), An Anti-Cancer Chemotherapy Agent 1/20/2016
Merck & Co. (MRK) Launches Vivera In Latin America 1/20/2016
Akorn, Inc. (AKN) Launches Buprenorphine/Naloxone Sublingual Tablets And Tobramycin Injection 1/19/2016
Mylan (MYL) Launches Generic Felbatol Tablets 1/19/2016
Virocyt Releases ViroTag AAV2-3: Rapid And Direct Quantification Of Gene Therapy Viral Vectors 1/19/2016
Kedrion Biopharma Expands Immunoglobulin Therapies Portfolio, Gains Commercial Rights In The U.S. To BIVIGAM, A Recently Approved IGIV Brand 1/19/2016
Lightlake (LLTP) Announces Adapt Pharma Facilitates NARCAN (Naloxone Hydrochloride) Nasal Spray Access To 62,000 State And Local Public Entities 1/19/2016
Plandai Biotechnology, Inc. (PLPL.OB) Announces Phytofare Used As Key Ingredient In New Fat Burner Product 1/14/2016
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Discusses The Current Cold Season And Announces Launch Of New Product Line, TK Supplements 1/14/2016
Adapt Pharma Facilitates NARCAN (Naloxone Hydrochloride) Nasal Spray Access To State And Local Public Entities 1/14/2016
Titan Pharmaceuticals (TTP) And Braeburn Pharma Announce FDA Advisory Committee Recommends Approval Of Probuphine, First 6-Month Implant To Treat Opioid Addiction 1/13/2016
SGI-DNA Launches Automated Cloning Module For The BioXp 3200 System And Reaches Another Instrument Milestone 1/13/2016
Gilead (GILD) Should Have Investors Giddy Over Continued HCV Dominance at J.P. Morgan 1/13/2016
ImpediMed Inc. Announces U.S. Commercial Launch Of L-Dex System For Assessment Of Lymphedema In Cancer Survivors 1/12/2016
ArcherDX Launches SureShot Triple Fusion-Positive NGS Control 1/12/2016
Hi-Tech Pharmaceuticals Announces OTC Nationwide Launch Of New Diet Pill -- Ionamin -- Backed By Clinical Study 1/12/2016
Zambon Launches Xadago (Safinamide) In Switzerland For Patients With Parkinson’s Disease 1/12/2016
Pfizer (PFE) Jacked Up Prices of More Than 100 Drugs on Jan. 1 1/11/2016
Why Merck & Co. (MRK) May Find Twitter an Unfriendly Environment to Be In 1/11/2016
Swedish Orphan Biovitrum Announces Commercial Launch Of Elocta In First Countries In Europe 1/11/2016
New Haven Pharmaceuticals Announces Availability of DURLAZA, First And Only Once-Daily 24-Hour Aspirin 1/8/2016
Mylan (MYL) Launches Generic Harvoni (Ledipasvir/Sofosbuvir) Under The Brand Name Myhep LVIR In India 1/7/2016
EffRx: First-In-Class Osteoporosis Treatment Binosto Launches In South Korea 1/7/2016
Lupin (LUPN.BO) Launches Generic Ortho Tri-Cyclen Lo Tablets In The US 1/6/2016
Mylan (MYL) Launches Generic Ortho Tri-Cyclen Lo Tablets 1/5/2016
Teva (TEVA) Announces Launch Of Generic Ortho Tri-Cyclen Lo In The United States 1/5/2016
Osiris Therapeutics, Inc. (OSIR) Provides Update On Coverage For Grafix 1/5/2016
Analyzing Gilead (GILD)'s Gamble on a Drug Both AbbVie (ABBV) and Johnson & Johnson (JNJ) Gave Up On 1/4/2016
Alimera Sciences (ALIM) Announces ILUVIEN J Code J7313 Is Now Active 1/4/2016
Allergan (AGN) And Perrigo (PRGO) Announce First-To-Market Launch Of Store Brand Equivalent To Mucinex D 600mg ER Tablets 1/4/2016
Bioventus Launches DUROLANE For Osteoarthritis Patients In Taiwan 1/4/2016



//-->